StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Monday. The firm issued a hold rating on the stock.
China Pharma Trading Down 2.8 %
Shares of CPHI opened at $0.24 on Monday. The company’s fifty day moving average is $0.22 and its two-hundred day moving average is $0.26. China Pharma has a fifty-two week low of $0.17 and a fifty-two week high of $1.16. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19.
China Pharma (NYSE:CPHI – Get Free Report) last posted its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The business had revenue of $0.93 million for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- What is the NASDAQ Stock Exchange?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How to Invest in Small Cap Stocks
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- What is the Shanghai Stock Exchange Composite Index?
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
